CRISPR/Cas9 deletion of SOX2 Regulatory Region 2 (SRR2) decreases SOX2 malignant activity in glioblastoma

Saenz-Antonanzas, A; Moncho-Amor, V; Elua-Pinin, A; Rizzoti, K; Lovell-Badge, R; Matheu, A

NEURO-ONCOLOGY, 2022; 24 ():